Last reviewed · How we verify

CYT004-MelQbG10 intra nodal injection

Cytos Biotechnology AG · Phase 2 active Biologic

CYT004-MelQbG10 intra nodal injection is a Therapeutic vaccine Biologic drug developed by Cytos Biotechnology AG. It is currently in Phase 2 development for Melanoma.

CYT004-MelQbG10 is a therapeutic vaccine designed to stimulate an immune response against melanoma.

CYT004-MelQbG10 is a therapeutic vaccine designed to stimulate an immune response against melanoma. Used for Melanoma.

At a glance

Generic nameCYT004-MelQbG10 intra nodal injection
SponsorCytos Biotechnology AG
Drug classTherapeutic vaccine
ModalityBiologic
Therapeutic areaOncology
PhasePhase 2

Mechanism of action

It works by presenting antigens from melanoma cells to the immune system, triggering a specific immune response against the tumor. This approach aims to induce a long-lasting immune memory, potentially leading to sustained tumor control.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about CYT004-MelQbG10 intra nodal injection

What is CYT004-MelQbG10 intra nodal injection?

CYT004-MelQbG10 intra nodal injection is a Therapeutic vaccine drug developed by Cytos Biotechnology AG, indicated for Melanoma.

How does CYT004-MelQbG10 intra nodal injection work?

CYT004-MelQbG10 is a therapeutic vaccine designed to stimulate an immune response against melanoma.

What is CYT004-MelQbG10 intra nodal injection used for?

CYT004-MelQbG10 intra nodal injection is indicated for Melanoma.

Who makes CYT004-MelQbG10 intra nodal injection?

CYT004-MelQbG10 intra nodal injection is developed by Cytos Biotechnology AG (see full Cytos Biotechnology AG pipeline at /company/cytos-biotechnology-ag).

What drug class is CYT004-MelQbG10 intra nodal injection in?

CYT004-MelQbG10 intra nodal injection belongs to the Therapeutic vaccine class. See all Therapeutic vaccine drugs at /class/therapeutic-vaccine.

What development phase is CYT004-MelQbG10 intra nodal injection in?

CYT004-MelQbG10 intra nodal injection is in Phase 2.

What are the side effects of CYT004-MelQbG10 intra nodal injection?

Common side effects of CYT004-MelQbG10 intra nodal injection include Injection site reactions, Fatigue, Headache.

Related